Yash P. Ashara, MBBS

Detroit Medical Center/Wayne State University

Poster(s):

• P3280 - Analyzing Treatment Safety: A Comparative Review of Reported Adverse Events in Ulcerative Colitis Patients Treated With Upadacitinib, Ustekinumab, and Adalimumab Using Nationwide Pharmacovigilance Data
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT

• P3281 - A Comparison of Adverse Events of Upadacitinib and Vedolizumab with Adalimumab in Ulcerative Colitis: Insights into Real-World Data From a Pharmacovigilance Database
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT

• P3282 - Comprehensive Analysis of Reported Adverse Events for Risankizumab-Rzaa, Ustekinumab, and Adalimumab in Crohn’s Disease: Unveiling Real-World Safety Insights From Pharmacovigilance Database
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT

• P3395 - Not All That Heals Is Harmless: A Case of Infliximab-Induced Acute Interstitial Nephritis
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT